157
|
470
|
8ewlA |
Crystal structure of cyp3a4 bound to an inhibitor |
175
|
454
|
7wg0A |
Structure of the manganese protoporphyrin ix-reconstituted cyp102a1 heme domain with n-palmitoyl-l-phenylalanine |
165
|
453
|
7wdhA |
Crystal structure of the p450 bm3 heme domain mutant f87a in complex with n-imidazolyl-hexanoyl-l-phenylalanine, phenol and hydroxylamine |
171
|
454
|
7wy1A |
Structure of the oxomolybdenum mesoporphyrin ix-reconstituted cyp102a1 haem domain with n-enanthyl-l-prolyl-l-phenylalanine in complex with styerene |
164
|
454
|
7wdeA |
Crystal structure of the p450 bm3 heme domain mutant f87l in complex with n-imidazolyl-hexanoyl-l-phenylalanine, styrene and hydroxylamine |
185
|
454
|
7wy4A |
Structure of the cyp102a1 f87a haem domain with n-enanthyl-l-prolyl-l-phenylalanine in complex with styrene |
180
|
454
|
7wy3A |
Structure of the oxomolybdenum mesoporphyrin ix-reconstituted cyp102a1 f87v mutant haem domain with n-(5-cyclohexyl)valeroyl-l-phenylalanine in complex with styrene |
177
|
454
|
7wy2A |
Structure of the oxomolybdenum mesoporphyrin ix-reconstituted cyp102a1 f87a mutant haem domain with n-enanthyl-l-prolyl-l-phenylalanine in complex with styrene |
165
|
454
|
7wdiA |
Crystal structure of the p450 bm3 heme domain mutant f87k in complex with n-imidazolyl-hexanoyl-l-phenylalanine and hydroxylamine |
162
|
454
|
7wddA |
Crystal structure of the p450 bm3 heme domain mutant f87k in complex with n-imidazolyl-hexanoyl-l-phenylalanine, styrene and hydroxylamine |
158
|
454
|
7wdgA |
Crystal structure of the p450 bm3 heme domain mutant f87l in complex with n-imidazolyl-hexanoyl-l-phenylalanine, phenol and hydroxylamine |
174
|
454
|
7w9dA |
Crystal structure of the oxomolybdenum mesoporphyrin ix-reconstituted cyp102a1 (p450bm3) heme domain with n-hexadecanoyl-l-homoserine |
167
|
452
|
7w97A |
Crystal structure of the cyp102a1 (p450bm3) heme domain with n-hexadecanoyl-l-homoserine |
172
|
454
|
7w9jA |
Crystal structure of the oxomolybdenum mesoporphyrin ix-reconstituted cyp102a1 (p450bm3) heme domain with n-dodecanoyl-l-homoserine lactone |
161
|
472
|
8dycA |
Human cyp3a4 bound to a substrate |
140
|
469
|
7uazA |
Crystal structure of human cyp3a4 with the caged inhibitor |
131
|
468
|
7uayA |
Crystal structure of human cyp3a4 with the caged inhibitor |
153
|
470
|
7ufdA |
Human cyp3a4 bound to an inhibitor |
146
|
471
|
7ufeA |
Human cyp3a4 bound to an inhibitor |
142
|
468
|
7uffA |
Human cyp3a4 bound to an inhibitor |
164
|
471
|
7ufbA |
Cyp3a4 bound to an inhibitor |
147
|
470
|
7uf9A |
Cyp3a4 bound to an inhibitor |
147
|
470
|
7ufaA |
Cyp3a4 bound to an inhibitor |
152
|
470
|
7ufcA |
Human cyp3a4 bound to an inhibitor |
168
|
473
|
7sv2A |
Human cytochrome p450 (cyp) 3a5 ternary complex with azamulin |
144
|
470
|
7ladA |
Clobetasol propionate bound to cyp3a5 |
169
|
463
|
7rl2A |
Crystal structure of the human cytochrome p450 2c9*8 (cyp2c9*8) genetic variant in complex with the drug losartan |
177
|
454
|
7d0tA |
Structure of the cyp102a1 haem domain with n-carboxybenzyl-l-prolyl-l-phenylalanine in complex with (s)-1-indanylamine |
178
|
454
|
7d0uA |
Structure of the cyp102a1 haem domain with n-enanthyl-l-prolyl-l-phenylalanine in complex with ethylamine |
176
|
454
|
7d1fA |
Structure of the cyp102a1 haem domain with n-enanthyl-l-prolyl-l-phenylalanine in complex with methylamine |
179
|
455
|
7cx8A |
Structure of the cyp102a1 haem domain with n-(5-cyclohexyl)valeroyl-l-phenylalanine in complex with (r)-1-tetralylamine |
176
|
454
|
7conA |
Structure of the cyp102a1 haem domain with n-{2-[4-(trifluoromethoxy)phenoxy]}acetoyl-l-phenylalanine in complex with n-propylamine |
169
|
453
|
7cvrA |
Structure of the cyp102a1 haem domain with n-carboxybenzyl-l-prolyl-l-phenylalanine in complex with (s)-1-tetralylamine |
175
|
454
|
7cp8A |
Structure of the cyp102a1 haem domain with n-(5-cyclohexyl)valeroyl-l-phenylalanine in complex with (r)-1-indanylamine |
181
|
454
|
7cknA |
Structure of the cyp102a1 haem domain with n-{2-[4-(trifluoromethoxy)phenoxy]}acetoyl-l-phenylalanine in complex with isopropylamine |
178
|
454
|
7cooA |
Structure of the cyp102a1 haem domain with n-carboxybenzyl-l-prolyl-l-phenylalanine in complex with cyclohexylamine |
179
|
455
|
7cx6A |
Structure of the cyp102a1 haem domain with n-(5-cyclohexyl)valeroyl-l-phenylalanine in complex with (r)-(+)-1-phenylethylamine |
181
|
454
|
7cziA |
Structure of the cyp102a1 haem domain with n-{2-[4-(trifluoromethoxy)phenoxy]}acetoyl-l-phenylalanine |
162
|
473
|
7mk8A |
Crystal structure of a surface mutant of human fetal-specific cyp3a7 bound to dithiothreitol |
155
|
470
|
7ks8A |
Crystal structure of human cyp3a4 with the caged inhibitor |
137
|
469
|
7ksaA |
Crystal structure of human cyp3a4 with the caged inhibitor |
126
|
469
|
7kvjA |
Human cyp3a4 bound to an inhibitor |
149
|
469
|
7kvsA |
Human cyp3a4 bound to an inhibitor |
142
|
468
|
7kvoA |
Human cyp3a4 bound to an inhibitor |
145
|
470
|
7kvkA |
Human cyp3a4 bound to an inhibitor |
137
|
468
|
7kvqA |
Human cyp3a4 bound to an inhibitor |
144
|
469
|
7kviA |
Human cyp3a4 bound to an inhibitor |
130
|
468
|
7kvhA |
Human cyp3a4 bound to an inhibitor |
153
|
469
|
7kvpA |
Human cyp3a4 bound to an inhibitor |
140
|
468
|
7kvnA |
Human cyp3a4 bound to an inhibitor |